122 related articles for article (PubMed ID: 10595380)
21. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.
Cohen DJ; Breall JA; Ho KK; Kuntz RE; Goldman L; Baim DS; Weinstein MC
Circulation; 1994 Apr; 89(4):1859-74. PubMed ID: 8149551
[TBL] [Abstract][Full Text] [Related]
22. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
Chino M; Sakamoto M; Sasaki T; Isshiki T
J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
[TBL] [Abstract][Full Text] [Related]
23. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
Gray DT; Veenstra DL
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):618-24. PubMed ID: 12658204
[TBL] [Abstract][Full Text] [Related]
24. [Cost-effectiveness of coronary angioplasty procedures in Poland].
Gasior M; Gierlotka M; Gasior U; Chodór P; Lekston A; Klosa Z; Balcarek J; Kalarus Z; Poloński L; Zembala M
Kardiol Pol; 2004 Jul; 61(7):42-7; discussion 48. PubMed ID: 15338017
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
Cohen DJ; Murphy SA; Baim DS; Lavelle TA; Berezin RH; Cutlip DE; Ho KK; Kuntz RE;
J Am Coll Cardiol; 2004 Nov; 44(9):1801-8. PubMed ID: 15519010
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of minimally invasive cardiac operations.
Ferraris VA; Ferraris SP
Heart Surg Forum; 2001; 4 Suppl 1():S30-4. PubMed ID: 11178305
[TBL] [Abstract][Full Text] [Related]
27. Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials.
Biondi-Zoccai GG; Abbate A; Agostoni P; Parisi Q; Turri M; Anselmi M; Vassanelli C; Zardini P; Biasucci LM
Ital Heart J; 2003 Apr; 4(4):271-80. PubMed ID: 12784781
[TBL] [Abstract][Full Text] [Related]
28. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
[TBL] [Abstract][Full Text] [Related]
29. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
[TBL] [Abstract][Full Text] [Related]
30. Clinical benefit of small vessel stenting: one-year follow-up of the SISCA trial.
Moer R; Myreng Y; Mølstad P; Albertsson P; Gunnes P; Lindvall B; Wiseth R; Arne KY; Golf S
Scand Cardiovasc J; 2002 Mar; 36(2):86-90. PubMed ID: 12028870
[TBL] [Abstract][Full Text] [Related]
31. [Coronary angioplasty in elderly patients].
Liistro F; Colombo A
Ital Heart J Suppl; 2002 Jan; 3(1):1-8. PubMed ID: 11899566
[TBL] [Abstract][Full Text] [Related]
32. Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial.
Balducelli M; Varani E; Vecchi G; Paloscia L; Manari A; Santarelli A; Cappi B; Shoeib A; Valenti S; Maresta A;
Minerva Cardioangiol; 2007 Jun; 55(3):281-9. PubMed ID: 17534246
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of direct stenting in coronary angioplasty.
Taylor AJ; Broughton A; Federman J; Walton A; Keighley C; Haikerwal D; Krawczyszyn M; Shaw J; Goods C
J Invasive Cardiol; 2000 Nov; 12(11):560-5. PubMed ID: 11060569
[TBL] [Abstract][Full Text] [Related]
34. Common sense, dollars and cents, and drug-eluting stents.
Vaitkus PT
J Am Coll Cardiol; 2006 Jul; 48(2):268-9. PubMed ID: 16843173
[No Abstract] [Full Text] [Related]
35. [Clinical and economic cost-benefit relations in treatment of patients with coronary heart disease].
Höher M; Hombach V
Z Kardiol; 1998; 87 Suppl 2():8-19. PubMed ID: 9827456
[TBL] [Abstract][Full Text] [Related]
36. The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs.
Sukin CA; Baim DS; Caputo RP; Ho KK; Laham RJ; Flatley MG; Carrozza JP; Cohen DJ
Am J Cardiol; 1997 Feb; 79(3):275-80. PubMed ID: 9036744
[TBL] [Abstract][Full Text] [Related]
37. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.
Cohen DJ; Breall JA; Ho KK; Weintraub RM; Kuntz RE; Weinstein MC; Baim DS
J Am Coll Cardiol; 1993 Oct; 22(4):1052-9. PubMed ID: 8409040
[TBL] [Abstract][Full Text] [Related]
38. [Coronary stents. Where are we? Where are we going?].
Gaxiola E; Vlietstra RE; Pepine CJ
Arch Inst Cardiol Mex; 1998; 68(4):337-45. PubMed ID: 9810372
[No Abstract] [Full Text] [Related]
39. Coronary artery stents. American College of Cardiology.
Pepine CJ; Holmes DR
J Am Coll Cardiol; 1996 Sep; 28(3):782-94. PubMed ID: 8772772
[No Abstract] [Full Text] [Related]
40. Antithrombotic therapy after coronary-artery stenting.
LoGerfo FW
N Engl J Med; 1999 Apr; 340(17):1365-6; author reply 1367-8. PubMed ID: 10223874
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
